Sinister self-sacrifice: The contribution of apoptosis to malignancy

Frontiers in Immunology

Volumn 5, Issue JUL, 2014, Pages

  Willems, Jorine J L P ^a   Arnold, Benjamin P ^a   Gregory, Christopher D ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

Apoptosis; Inflammation; Lactoferrin; Phagocytosis; Tumor associated macrophages

Indexed keywords

EID: 84905663507     PISSN: None     EISSN: 16643224     Source Type: Journal    
DOI: 10.3389/fimmu.2014.00299     Document Type: Note

References (46)

1. Wyllie AH. The biology of cell death in tumours. Anticancer Res (1985) 5(1):131-6.
2. Harris NL. A practical approach to the pathology of lymphoid neoplasms: a revised European-American classification from the International Lymphoma Study Group. Important Adv Oncol (1995):111-40.
3. Gregory CD, Pound JD. Cell death in the neighbourhood: direct microenvironmental effects of apoptosis in normal and neoplastic tissues. J Pathol (2010) 223(2):177-94. doi:10.1002/path.2792
4. Huang Q, Li F, Liu X, Li W, Shi W, Liu F-F, et al. Caspase 3-mediated stimulation of tumor cell repopulation during cancer radiotherapy. Nat Med (2011) 17(7):860-6. doi:10.1038/nm.2385
5. Revesz L. Effect of tumour cells killed by x-rays upon the growth of admixed viable cells. Nature (1956) 178(4547):1391-2. doi:10.1038/1781391a0
6. Balkwill F, Mantovani A. Inflammation and cancer: back to Virchow? Lancet (2001) 357(9255):539-45. doi:10.1016/S0140-6736(00)04046-0
7. Coussens LM, Werb Z. Inflammation and cancer. Nature (2002) 420(6917):860-7. doi:10.1038/nature01322
8. Dvorak HF. Tumors: wounds that do not heal: similarities between tumor stroma generation and wound healing. N Engl J Med (1986) 315(26):1650-9. doi:10.1056/NEJM198612253152606
9. Sica A, Larghi P, Mancino A, Rubino L, Porta C, Totaro MG, et al. Macrophage polarization in tumour progression. Semin Cancer Biol (2008) 18(5):349-55. doi:10.1016/j.semcancer.2008.03.004
10. Biswas SK, Mantovani A. Macrophage plasticity and interaction with lymphocyte subsets: cancer as a paradigm. Nat Immunol (2010) 11(10):889-96. doi:10.1038/ni.1937
11. Senovilla L, Vacchelli E, Galon J, Adjemian S, Eggermont A, Fridman WH, et al. Trial watch: prognostic and predictive value of the immune infiltrate in cancer. Oncoimmunology (2012) 1(8):1323-43.
12. Qian B-Z, Pollard JW. Macrophage diversity enhances tumor progression and metastasis. Cell (2010) 141(1):39-51. doi:10.1016/j.cell.2010.03.014
13. Elliott MR, Chekeni FB, Trampont PC, Lazarowski ER, Kadl A, Walk SF, et al. Nucleotides released by apoptotic cells act as a find-me signal to promote phagocytic clearance. Nature (2009) 461(7261):282-6. doi:10.1038/nature08296
14. Chekeni FB, Elliott MR, Sandilos JK, Walk SF, Kinchen JM, Lazarowski ER, et al. Pannexin 1 channels mediate "find-me" signal release and membrane permeability during apoptosis. Nature (2010) 467(7317):863-7. doi:10.1038/nature09413
15. Lauber K, Bohn E, Kröber SM, Xiao Y-J, Blumenthal SG, Lindemann RK, et al. Apoptotic cells induce migration of phagocytes via caspase-3-mediated release of a lipid attraction signal. Cell (2003) 113(6):717-30. doi:10.1016/S0092-8674(03)00422-7
16. Truman LA, Ford CA, Pasikowska M, Pound JD, Wilkinson SJ, Dumitriu IE, et al. CX3CL1/fractalkine is released from apoptotic lymphocytes to stimulate macrophage chemotaxis. Blood (2008) 112(13):5026-36. doi:10.1182/blood-2008-06-162404
17. Bournazou I, Pound JD, Duffin R, Bournazos S, Melville LA, Brown SB, et al. Apoptotic human cells inhibit migration of granulocytes via release of lactoferrin. J Clin Invest (2009) 119(1):20-32. doi:10.1172/JCI36226
18. Kobara M, Sunagawa N, Abe M, Tanaka N, Toba H, Hayashi H, et al. Apoptotic myocytes generate monocyte chemoattractant protein-1 and mediate macrophage recruitment. J Appl Physiol (2008) 104(3):601-9. doi:10.1152/japplphysiol.00254.2007
19. Marques-da-Silva C, Burnstock G, Ojcius DM, Coutinho-Silva R. Purinergic receptor agonists modulate phagocytosis and clearance of apoptotic cells in macrophages. Immunobiology (2011) 216(1-2):1-11. doi:10.1016/j.imbio.2010.03.010
20. Boehme SA, Lio FM, Maciejewski-Lenoir D, Bacon KB, Conlon PJ. The chemokine fractalkine inhibits Fas-mediated cell death of brain microglia. J Immunol (2000) 165(1):397-403. doi:10.4049/jimmunol.165.1.397
21. White GE, Tan TC, John AE, Whatling C, McPheat WL, Greaves DR. Fractalkine has anti-apoptotic and proliferative effects on human vascular smooth muscle cells via epidermal growth factor receptor signalling. Cardiovasc Res (2010) 85(4):825-35. doi:10.1093/cvr/cvp341
22. Miksa M, Amin D, Wu R, Ravikumar TS, Wang P. Fractalkine-induced MFG-E8 leads to enhanced apoptotic cell clearance by macrophages. Mol Med (2007) 13(11-12):553-60. doi:10.2119/2007-00019.Miksa
23. Chapple DS, Mason DJ, Joannou CL, Odell EW, Gant V, Evans RW. Structure-function relationship of antibacterial synthetic peptides homologous to a helical surface region on human lactoferrin against Escherichia coli serotype O111. Infect Immun (1998) 66(6):2434-40.
24. Naot D, Callon KE, Grey A, Cooper GJ, Reid IR, Cornish J. A potential role for adrenomedullin as a local regulator of bone growth. Endocrinology (2001) 142(5):1849-57. doi:10.1210/endo.142.5.8152
25. Togawa J-I, Nagase H, Tanaka K, Inamori M, Nakajima A, Ueno N, et al. Oral administration of lactoferrin reduces colitis in rats via modulation of the immune system and correction of cytokine imbalance. J Gastroenterol Hepatol (2002) 17(12):1291-8. doi:10.1046/j.1440-1746.2002.02868.x
26. Zimecki M, Artym J, Chodaczek G, Kocieba M, Kruzel M. Effects of lactoferrin on the immune response modified by the immobilization stress. Pharmacol Rep (2005) 57(6):811-7.
27. Wyllie AH. Apoptosis and the regulation of cell numbers in normal and neoplastic tissues: an overview. Cancer Metastasis Rev (1992) 11(2):95-103. doi:10.1007/BF00048057
28. Savill J, Fadok V, Henson P, Haslett C. Phagocyte recognition of cells undergoing apoptosis. Immunol Today (1993) 14(3):131-6. doi:10.1016/0167-5699(93)90215-7y
29. Miles K, Clarke DJ, Lu W, Sibinska Z, Beaumont PE, Davidson DJ, et al. Dying and necrotic neutrophils are anti-inflammatory secondary to the release of alpha-defensins. J Immunol (2009) 183(3):2122-32. doi:10.4049/jimmunol.0804187
30. Bellamy W, Takase M, Yamauchi K, Wakabayashi H, Kawase K, Tomita M. Identification of the bactericidal domain of lactoferrin. Biochim Biophys Acta (1992) 1121(1-2):130-6. doi:10.1016/0167-4838(92)90346-F
31. Baker EN, Baker HM. Molecular structure, binding properties and dynamics of lactoferrin. Cell Mol Life Sci (2005) 62(22):2531-9. doi:10.1007/s00018-005-5368-9
32. Appelmelk BJ, An YQ, Geerts M, Thijs BG, de Boer HA, MacLaren DM, et al. Lactoferrin is a lipid A-binding protein. Infect Immun (1994) 62(6):2628-32.
33. Håversen L, Ohlsson BG, Hahn-Zoric M, Hanson LÅ, Mattsby-Baltzer I. Lactoferrin down-regulates the LPS-induced cytokine production in monocytic cells via NF-kappa B. Cell Immunol (2002) 220(2):83-95. doi:10.1016/S0008-8749(03)00006-6
34. Curran CS, Demick KP, Mansfield JM. Lactoferrin activates macrophages via TLR4-dependent and -independent signaling pathways. Cell Immunol (2006) 242(1):23-30. doi:10.1016/j.cellimm.2006.08.006
35. de la Rosa G, Yang D, Tewary P, Varadhachary A, Oppenheim JJ. Lactoferrin acts as an alarmin to promote the recruitment and activation of APCs and antigen-specific immune responses. J Immunol (2008) 180(10):6868-76. doi:10.4049/jimmunol.180.10.6868
36. Damiens E, El Yazidi I, Mazurier J, Duthille I, Spik G, Boilly-Marer Y. Lactoferrin inhibits G1 cyclin-dependent kinases during growth arrest of human breast carcinoma cells. J Cell Biochem (1999) 74(3):486-98. doi:10.1002/(SICI)1097-4644(19990901)74:3<486::AID-JCB16>3.0.CO;2-6
37. Ogden CA, Pound JD, Batth BK, Owens S, Johannessen I, Wood K, et al. Enhanced apoptotic cell clearance capacity and B cell survival factor production by IL-10-activated macrophages: implications for Burkitt's lymphoma. J Immunol (2005) 174(5):3015-23. doi:10.4049/jimmunol.174.5.3015
38. Hori M, Xiang S, Qi C-F, Chattopadhyay SK, Fredrickson TN, Hartley JW, et al. Non-Hodgkin lymphomas of mice. Blood Cells Mol Dis (2001) 27(1):217-22. doi:10.1006/bcmd.2000.0375
39. Lauber K, Muñoz LE, Berens C, Jendrossek V, Belka C, Herrmann M. Apoptosis induction and tumor cell repopulation: the yin and yang of radiotherapy. Radiat Oncol (2011) 6(1):176. doi:10.1186/1748-717X-6-176
40. Huynh ML. Phosphatidylserine-dependent ingestion of apoptotic cells promotes TGF-beta1 secretion and the resolution of inflammation. J Clin Invest (2002) 109(1):41-50. doi:10.1172/JCI200211638
41. Napirei M, Mannherz HG. Molecules involved in recognition and clearance of apoptotic/necrotic cells and cell debris. In: Krysko DV, Vandenabeele P, editors. Phagocytosis of Dying Cells: From Molecular Mechanisms to Human Disease. Dordrecht: Springer Verlag (2009). p. 103-45.
42. Grimsley C. Cues for apoptotic cell engulfment: eat-me, don't eat-me and come-get-me signals. Trends Cell Biol (2003) 13(12):648-56. doi:10.1016/j.tcb.2003.10.004
43. Wu Y, Tibrewal N, Birge RB. Phosphatidylserine recognition by phagocytes: a view to a kill. Trends Cell Biol (2006) 16(4):189-97. doi:10.1016/j.tcb.2006.02.003
44. Voll RE, Herrmann M, Roth EA, Stach C, Kalden JR, Girkontaite I. Immunosuppressive effects of apoptotic cells. Nature (1997) 390(6658):350-1. doi:10.1038/37022
45. Golpon HA. Life after corpse engulfment: phagocytosis of apoptotic cells leads to VEGF secretion and cell growth. FASEB J (2004) 18(14):1716-8. doi:10.1096/fj.04-1853fje
46. Weihua Z. Apoptotic cells initiate endothelial cell sprouting via electrostatic signaling. Cancer Res (2005) 65(24):11529-35. doi:10.1158/0008-5472.CAN-05-2718